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MicroRNAs are known to be involved in the pathogenesis of hepatocellular carcinoma (HCC). This
study aims to explore the potential biological function of miR-376a, which was found to be inhibited
after partial hepatectomy, in HCC. We discovered that miR-376a was frequently down-regulated in
HCC cell lines and HCC tissues, while higher relative level of miR-376a was signiﬁcantly associated
with high serum AFP level. Over-expression of miR-376a not only inhibited proliferation but
induced apoptosis in Huh7 cells. Additionally, p85a (PIK3R1) was identiﬁed as a direct and func-
tional target of miR-376a in Huh7 cells. Moreover, we conﬁrmed that p85a and miR-376a were
inversely correlated in HCC. These ﬁndings suggest that down-regulation of miR-376a may contrib-
ute to the development of HCC by targeting p85a.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MicroRNAs are endogenous non-coding RNAs of 19–25 nucleo-
tides in length that act as posttranscriptional regulators by binding
to the 30 UTR of target mRNAs [1]. Knowing that miRNAs are
involved in the initiation and progression of cancer [2], analysis
of the miRNAs and the related target genes may provide unique
insight into tumorigenesis and new strategies for improving the
diagnosis or treatment of hepatocellular carcinoma. In recent
years, several studies have described the roles of miRNA in the
development of hepatocellular carcinoma (HCC) [3] and found
some speciﬁc miRNA sets associated with the clinicopathological
features of HCC [4], including serum AFP level [5].
Several previous studies have characterized the molecular path-
ogenesis and pinpointed the dominant pathway of HCC [6–8], one
of the view is that activation of the PI3K/AKT pathway is a major
determinant in HCC carcinogenesis [9,10]. Phosphoinositide 3-ki-
nase is a dimeric enzyme [11] consisting of a catalytic (p110)
and a regulatory subunit (p85a). p85a is reported to be an onco-
gene in ovarian, colorectal [12] and prostate cancers [13], so anal-chemical Societies. Published by E
Biochemistry and Molecular
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k.ysis of microRNA that modulate p85a in HCC may provide unique
insights into activation of PI3K/AKT pathway.
One of the main pathogenesis of HCC is cirrhosis associated
hepatic regeneration after tissue damage [9]. Some studies have
strongly indicated that many factors involved in liver regeneration
are also implicated in the growth of occult tumors [14–16]. In a
preliminary study using a miRNA microarray analysis, miR-376a
was found inhibited in regenerating mouse liver tissue 3 h after
hepatectomy compared to the sham operation group. Considering
the resemblance of HCC and early phases of liver regeneration
in expression proﬁle [17], we hypothesized that miR-376a may
be involved in the tumorigenesis of HCC.
In this study, we determined the expression pattern of
miR-376a in HCC cell lines and cancerous tissues, validated its ef-
fect on proliferation and apoptosis in Huh7 cells, and investigated
its potential molecular mechanisms. Finally, we analyzed the cor-
relation between miR-376a and its target in HCC tissues. Our data
suggested that miR-376a may exert a tumor-suppressive effect
during HCC development via directly targeting p85a.
2. Materials and methods
2.1. Clinical materials
Forty-one cancerous and adjacent non-cancerous tissue speci-
mens were obtained from patients with informed consent wholsevier B.V. All rights reserved.
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Surgery Hospital (Shanghai, China) between 2010 and 2011. The
specimens were frozen in liquid nitrogen immediately after surgi-
cal resection and preserved at 80 C. Both cancerous and non-
cancerous specimens were histologically conﬁrmed, and all HCC
tumors originated from HBV infection. The study was approved
by the Institute Research Ethics Committee of the Eastern Hepa-
tobiliary Surgery Hospital.2.2. qRT-PCR
Total RNA was extracted from the tissue specimens using Trizol
reagent (Invitrogen, Carlsbad, CA, USA). Quantiﬁcation of miR-376a
was performed by stem-loop RT-PCR. cDNA was generated using
the Reverse Transcription System Kit (MBI Fermentas, Vilnius, Lith-
uania). Quantitative real-time PCR was performed using a standard
SYBR Green I kit (TOYOBO, Osaka, Japan) and PCR-speciﬁc ampliﬁ-
cation was applied on ABI 7300 (Applied Biosystems, Darmstadt,
Germany) machine. U6 and GAPDH were used as the endogenous
controls for the normalization of the amount of miRNA and total
mRNA in each specimen. The relative expression level of miRNA
and mRNA by qRT-PCR was calculated using the comparative
2DDCt method. Primers are listed in Table S1.Fig. 1. miR-376a is frequently down-regulated during early phase of regenerating mic
regenerating mice liver tissue 3 h after hepatectomy by quantitative real-time PCR (qR
underwent surgery without liver resection. (B) The expression pattern of miR-376a in HC
normalized to U6 (P = 0.01). Statistical analysis was performed by paired-sample t-test.
L02 cells. The relative level of miR-376a in HCC cell lines was calculated using the comp
from at least three independent experiments and are shown as the means ± S.D. The da2.3. Cell culture and transfection
HCC cell lines (HepG2, Huh7 and SMMC-7721) and the normal
liver cell line (L02) were obtained from the Institute of Biochemis-
try and Cell Biology (Shanghai, China). All cell lines were cultured
in DMEM (Biowest, Loire, France) with 10% fetal bovine serum
(Biowest, Loire, France) in a humidiﬁed atmosphere containing
5% CO2 at 37 C. MiR-376a mimics, negative control RNA, siRNA-
PIK3R1 (5691nt, GenBank accession no. NM_181504) and control
siRNA were obtained from GenePharma (Shanghai, China). RNA se-
quences are listed in Table S1. The recombinant plasmid (PIK3R1-
EGFP) was obtained from GeneChem (Shanghai, China). Transfec-
tion was performed using Lipofectamine 2000 (Invitrogen, Carls-
bad, CA, USA) according to the manufacturer’s protocols.
2.4. Cell proliferation assay
Huh7 cells were transfected with the miR-376a mimics or the
negative control, PIK3R1 siRNA or the control siRNA (all at
40 pmol) in the 24-well plate. After 24-h transfection, cells were
reseeded in 96-well plates at a density of 200 cells per well. At var-
ious time points (day 1, 2, 3 and 4), 20 ll methylthiazoletetrazoli-
um (MTT) solution (5 mg/mL) was added into the culture medium
for 4-h incubation. Then 150 ll dimethyl sulfoxide (DMSO) wase liver tissues, in HCC samples and cell lines. (A) The expression of miR-376a in
T-PCR) analysis. PH group, animals underwent partial hepatectomy; SH, animals
C samples by qRT-PCR. The expression of miR-376a (log10 scale on the Y-axis) was
(C) Expression of mature miR-376a was detected in HepG2, Huh7, SMMC-7721 and
arative 2DDCt method and standardised to that in L02 cell. The data were obtained
ta were subjected to t test. ⁄⁄Represented P < 0.01 and ⁄represented P < 0.05.
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tion, the absorbance of each sample was recorded at 570 nm. The
experiment was performed in triplicate.
2.5. Apoptosis assay
Huh7 cells (2  105) were plated in 12-well plates and transfec-
tedwith themiR-376amimics or the negative control, PIK3R1 siRNA
or the control siRNA, and PIK3R1-EGFP (4 lg). After 48-h incubation,
the cells were collected for apoptosis analysis by ﬂow cytometry.
The number of apoptotic cells was determined with the annexin V/
FITC detection kit (Keygentec, Nanjing, China) according to theman-
ufacturer’s instructions. Data acquisition and analysis were per-
formed using a FACSort Cytometer (FACSCA, New York, USA). The
apoptotic cells was the sum of the early and the late.
2.6. Tumorigenicity assay in nude mice
Four-week old BALB/c male nude mice were offered by the
Experimental Animal Center of Secondary Military Medical Univer-
sity. Huh7 cells (1  106) treated with the miR-376a mimics or the
negative control were suspended in 100 ll PBS and inoculated sub-
cutaneously into either side of nude mice, next, the mice were
housed until they developed palpable tumors. On day 14, the mice
were sacriﬁced, and the tumors were removed.Table 1
Associations between the expression of miR-376a and clinicopathologic features in
patients with hepatocellular carcinoma.
n MiR-376a relative level
HBV infection 41 Low (21) High (20)
Tumor size
<5 cm 21 8 13
P5 cm 20 13 7
P 0.121
Tumor capsule
Void or partial 27 16 11
Intact 14 5 9
P 0.197
AFP
620 ng/ml 18 13 5
>20 ng/ml 23 8 15
P 0.028
Microvascular invasion
Yes 6 4 2
No 35 17 18
P 0.663
Cirrhosis
Yes 33 15 18
No 8 6 2
P 0.238
TNM
I or II 20 8 12
III 21 13 8
P 0.217
The level of miR-376a in cancerous tissues relative to its non-cancerous control was
calculated using the formula: 2DDCt, the median value of all 41 HCC samples were
chosen as the cut-off point for separating tumors with low relative level of miR-
376a from high relative level of miR-376a. Correlations between miRNA expression
and clinicopathologic parameters were analyzed by the chi-square test.2.7. Construction of vectors
The 30 UTR of PIK3R1 containing the miR-376a recognition se-
quence was ampliﬁed by PCR from genomic DNA. The PCR product
was then cloned into the XbaI/FseI site of the pGL4.13 vector (Pro-
mega, Madison, WI). A mutant PIK3R1 30 UTR was synthesized
using a site-directed mutagenesis kit (TaKaRa, Toyko, Japan). The
primers used in this study are listed in Table S1.
2.8. Luciferase reporter assay
Huh7 cells (1  105) were cotransfected with 500 ng pGL4.13-
PIK3R1-WT/pGL4.13-PIK3R1-Mut constructs and the miR-376a
mimics or the negative control in a 24-well plate. Each sample
was cotransfected with 50 ng renilla luciferase control plasmid
(pGL4.7) to monitor the transfection efﬁciency (Promega, Madison,
USA). After 48-h incubation, a luciferase activity assay was per-
formed using the dual luciferase reporter assay system (Promega,
Madison, USA).
2.9. Western blot analysis
The expression levels of p85a, p-AKT (Thr308), p53 and GAPDH
were determined in total cell extracts from transfected cells (the
miR-376a mimics or the negative control). Total cell lysate was
prepared in 1 SDS buffer and separated by SDS-PAGE, then pro-
teins were transferred onto a nitrocellulose membrane (Boguang,
Shanghai, China). After 6-h incubation with antibodies speciﬁc
for either p85a (Epitomics, Burlingame, CA), p-AKT (Abgent, San
Diego, CA, USA), GAPDH (Abgent, San Diego, CA, USA) or p53 (Ab-
gent, San Diego, CA, USA), the blotting was incubated with goat
anti-rabbit IgG antibody and visualized using enhanced chemilu-
minescence (Pierce, Rockford, USA).
2.10. Immunohistochemistry (IHC)
The cancerous and adjacent non-cancerous tissue blocks were
cut into 5 lm sections and ﬁxed with formalin, embedded with
parafﬁn. Samples were ﬁrst incubated with an anti-p85a antibody(Epitomics, Burlingame, CA), and then incubated with a biotinyla-
ted secondary antibody using the ChemMate EnVision Kit (K5001,
DAKO, Hamburg, Germany). All stained sections were examined
under a light microscope at magniﬁcation of 400.
2.11. Statistical analysis
Data are expressed as the means ± standard deviation from
three independent experiments. Data were analyzed by using t-
test, ANOVA and Pearson’s correlation coefﬁcient as indicated in
the ﬁgure legends. All P values were two sided and obtained by
using the SPSS 13.0 software package. P < 0.05 was considered sta-
tistically signiﬁcant.
3. Results
3.1. MiR-376a is down-regulated during early phase of regenerating
mice liver tissues, in human HCC tissues frequently and HCC cell lines
We measured the expression of miR-376a in regenerating mice
liver tissue 3 h after hepatectomy by qRT-PCR. As shown in Fig. 1A,
miR-376a level decreased during the early phase of liver regenera-
tion in mice. To determine the status of miR-376a in HCC, 41 paired
cancerous and adjacent non-cancerous samples were analyzed by
qRT-PCR. As shown in Fig. 1B, miR-376a was down-regulated in
80.5% (33/41) of the HCC samples (P < 0.05). In addition, 27
(65.9%) of the 41 HCC samples showed more than 40% reduction
of miR-376a level as compared with the adjacent non-cancerous
samples. Additionally, as revealed in Fig. 1C, miR-376a expression
in HCC cell lines (HepG2, Huh7 and SMMC-7721) was signiﬁcantly
lower than that in the human fetal liver cell line (L02), suggesting
that down-regulation of miR-376a was a common event in human
HCC tissues and cell lines.
Y. Zheng et al. / FEBS Letters 586 (2012) 2396–2403 23993.2. Higher relative level of miR-376a was associated with a high level
of serum AFP
To further investigate the clinicopathological signiﬁcance of
miR-376a level in HCC patients, correlations between miR-376a
expression and clinicopathologic parameters were analyzed by
the chi-square test. Correlation analysis (Table 1) showed that pa-
tients with higher relative level of miR-376a in tumor/adjacent
non-tumor tissues tended to have elevated serum AFP level.
3.3. MiR-376a inhibits Huh7 cell proliferation
Compared with the other HCC cell lines, Huh7 cells expressed
the least miR-376a. Therefore, Huh7 cell line was used as the cell
model in this study. To validate the effect of miR-376a on Huh7
cell proliferation, MTT cell proliferation assay and apoptosis anal-
ysis were used as described in ‘‘Section 2’’. Brieﬂy, Huh7 cells
were treated with miR-376a or NC. MTT assay was performed at
one-day intervals and apoptosis analysis was conducted at 48 h
after transfection. As shown in Fig. 2A, miR-376a repressed
Huh7 cell proliferation at day 3 (P = 0.006). The data of cellFig. 2. miR-376a inhibited cell proliferation in Huh7 cell. (A) Huh7 cell transfected with
absorbance of methylthiazoletetrazolium was recorded at 570 nm after staining. (B and C
‘‘ Section 2’’. The data were obtained from at least three independent experiments and are
(D) Nude mice inoculated with the miR-376a or NC transfected Huh7 cells in their ﬂankapoptosis analysis (Fig. 2B and C) showed that the percentage of
apoptotic cells in miR-376a and NC groups were (13.7 ± 1.09)%
and (7.2 ± 0.599)%, respectively (P = 0.005). These results indicated
that miR-376a had an inhibitory effect on the proliferation of
Huh7 cells.
To further conﬁrm the observations, nude mice bearing Huh7
xenografts were used to evaluate the role of miR-376a on tumor
cell proliferation in vivo. As shown in Fig. 2D, the miR-376a treated
Huh7 cells prevented tumor growth in nude mice. These ﬁndings
demonstrated that the growth inhibitory effect of miR-376a could
also be sustained in vivo.
3.4. MiR-376a down-regulates PIK3R1 directly
To explore the underlying molecular mechanism of miR-376a in
inhibiting proliferation and inducing apoptosis in Huh7 cells, puta-
tive target genes were predicted using TargetScan (http://www.tar-
getscan.org) and the pathway network of these candidate target
genes were analyzed using Molecule Annotation System (MAS,
http://bioinfo.capitalbio.com/mas). As shown in Fig. 3A, PIK3R1,
which encodes p85a, was deﬁned as the hub gene [18]. Hub genesmiR-376a or NC were seeded in 96-well plates and detected at 24-h intervals. The
) Cells treated with miR-376a or NC were analyzed by ﬂow cytometry as described in
shown as the means ± S.D. The data were analyzed by t test. ⁄⁄Represented P < 0.01.
s (left) and corresponding isolated tumor tissue (right).
Fig. 3. MiR-376a down-regulated the expression of PIK3R1 directly. (A) The pathway network of candidate target genes of miR-376 based KEGG was shaped by MAS
(Molecular Annotation System, http://bioinfo.capitalbio.com/mas). (B) miR-376a repressed PIK3R1 at mRNA level by qRT-PCR analysis. (C) miR-376a decreased protein level
of p85a and p-AKT (Thr308) by western blotting analysis. GAPDH was used as sample control. (D) MiR-376a binding site in the 30 UTR of PIK3R1 and their corresponding
mutated sites were constructed into a luciferase reporter vector (pGL4.13). (E) Huh7 cells were cotransfected with a luciferase reporter vector containing the 30 UTR (PIK3R1-
UTR) or mutated sequence of PIK3R1 (PIK3R1-mut-UTR) and miR-376a or NC in 24-well plate. The data were obtained from at least three independent experiments and are
shown as the means ± S.D. The data were analyzed by t test ⁄⁄P < 0.01.
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bilizing thenetwork and are central to theunderlyingbiological pro-
cesses [19,20].Moreover, the target genes of individualmiRNAs tend
to be hubs and bottlenecks in the networks [21,22]. Accordingly, the
gene of PIK3R1was assayed as the target in the present study.
QRT-PCR and Western blotting analysis revealed that miR-376a
reduced PIK3R1 both at mRNA and protein levels in Huh7 cells
(Fig. 3B and C). In addition, the protein level of p-AKT decreased
accordingly. These results suggested that the miR-376a mimics re-
duced the activity of PI3K/AKT pathway. To determine whether
PIK3R1 was regulated by miR-376a directly, the 30 UTR region of
PIK3R1 was fused to a luciferase reporter (pGL4.13). As shown in
Fig. 3E, the miR-376a mimics repressed the luciferase activity of
the wild type plasmid (PIK3R1-UTR) but not the mutant plasmid
(PIK3R1-mut-UTR), indicating that PIK3R1 is a direct target of
miR-376a.
3.5. Knockdown of PIK3R1 represses Huh7 cell proliferation and
induces apoptosis
PIK3R1 shRNAwas reported to inhibit the growth of gastric ade-
nocarcinoma cells and glioma cells in vitro and in vivo [23]. How-
ever, the function of PIK3R1 in HCC proliferation still needs to beconﬁrmed. To study the biological function of PIK3R1 in HCC cells,
Huh7 cells were transfected with PIK3R1 siRNA.
The knockdown efﬁciency of PIK3R1 was veriﬁed by qRT-PCR.
After PIK3R1 siRNA treatment, MTT and apoptosis assays were per-
formed. As presented in Fig. 4(B) and (C), PIK3R1 siRNA inhibited
Huh7 cell proliferation at day 3 (P = 0.045) and induced apoptosis
(P = 0.003). In other words, reduction of PIK3R1 mimicked the ef-
fect of miR-376a over-expression. These results conﬁrmed that
PIK3R1 was potentially involved in the miR-376a-regulated prolif-
eration and apoptosis.
3.6. Ectopic expression of PIK3R1 rescues cellular apoptosis
To test whether over-expression of PIK3R1 could rescue cell
apoptosis, plasmids (PIK3R1-EGFP) that expressed PIK3R1 were
transfected into Huh7 cells alone or along with miR-376a mimics.
The PIK3R1-EGFP plasmid enables visualization of transfection
efﬁciency 24 h post transfection via bright and ﬂuorescence
microscope (Fig. 5A). As revealed in Fig. 5(B) and (C), the apoptotic
cell population indeed fell when PIK3R1 was overexpressed or
coexpressed with miR-376a, suggesting that PIK3R1 inhibited
apoptosis and protected Huh7 cells from miR-376a-induced
apoptosis.
Fig. 4. Knockdown of PIK3R1 repressed HCC cell proliferation. (A) Identiﬁcation of PIK3R1 knockdown efﬁciency by siRNA via qRT-PCR. GAPDH was used as fold control. (B)
PIK3R1 silencing led to growth inhibition in Huh7 cells by MTT cell proliferation analysis. (C) PIK3R1 silencing induced apoptosis of Huh7 cells by ﬂow cytometry as described
in ‘‘ Section 2’’. The data were obtained from at least three independent experiments and are shown as the means ± S.D. The data were analyzed by t test.
Fig. 5. Ectopic expression of PIK3R1 rescued cellular apoptosis. (A) Fluorescence (right) and bright (left) photomicrographs of PIK3R1-EGFP-positive cells transfected by
PIK3R1- EGFP. Pictures were taken 24 h after transfection. (B and C) Ectopic expression of PIK3R1 led to apoptosis inhibition in Huh7 cells by ﬂow cytometry as described in
‘‘Section 2’’. The data were obtained from at least three independent experiments and are shown as the means ± S.D. The data were subjected to ANOVA.
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Fig. 6. Expression ofmiR-376a andp85a showed inverse correlation inHCC. (A) p85a is frequently upregulated inHCC tissues. The intensity for eachbandwas densitometrically
quantiﬁed, and the value under each lane indicated the relative level of p85a compared cancerous vs non-cancerous tissues. (B) miR-376a and p85awere inversely expressed
in 18 HCC tissues. Linear regression coefﬁcient and statistical signiﬁcance were indicated. Statistical analysis was performed using Pearson’s correlation coefﬁcient.
(C) Immunohistochemistry staining of p85a in HCC. Representative immunohistochemical stainings in HCC with noncancerous tissues (N) or cancerous tissues (T) shown.
2402 Y. Zheng et al. / FEBS Letters 586 (2012) 2396–24033.7. p85a (PIK3R1) is often up-regulated in HCC
To assess whether miR-376a potentially regulated the expres-
sion of p85a in HCC, p85a level was measured by western blot-
ting analysis in 18 HCC samples. As shown in Fig. 6(A) and (B),
the expression of p85a and miR-376a were inversely expressed
in HCC. Moreover, p85a were analyzed by immunohistochemis-
try, as revealed in Fig. 6C, p85a was clearly over-expressed in
cancerous samples than the adjacent non-cancerous samples.
Taken together, these observations suggested that decreased
expression of miR-376a triggered up-regulation of PIK3R1 par-
tially in HCC.
4. Discussion
Although microarray analysis on HCC has beenwidely performed
to ﬁnd microRNA related to carcinogenesis [24], the result is usually
uncertain owing to great variance of individual patients. Ample evi-
dence suggests that there is a strict connection linking liver regener-
ation and carcinogenesis [25], because some factors and pathways
that accelerate liver regeneration are also important for the prolifer-
ation, survival and metastasis of tumor cells, such as hepatocyte
growth factor (HGF), epidermal growth factor (EGF), Ras/Raf/MEK
and PI3K/AKT [14]. Therefore, we attempted to ﬁnd some microRNA
related to HCC from miRNA chip of liver regeneration.
Our preliminary study utilizing a miRNA microarray has found
that MiR-376a was down-regulated during the early phase of liverregeneration, which is consistent with other work [26]. In the pres-
ent study, we conﬁrmed that by qRT-PCR. Moreover, miR-376a was
found down-regulated in HCC cancer tissues, which agree with a
recent study of Cao XT [27], who determined the abundance of
the miRNome in the human liver and HCC, and found that miR-
376a abundance was very low but was often down-regulated in li-
ver cancer tissues. To conﬁrm the biological function of miR-376a
in liver cancer, we used Huh7 cell as the model cell. Our data
showed that miR-376a inhibited Huh7 cell proliferation and in-
duced apoptosis. Recently, some studies have described the role
of miR-376a in different cell models. For instance, miR-376a, with
adjacent miRNA in the same cluster, was identiﬁed as a potential
tumor suppressor in human epithelial ovarian cancer [28]. miR-
376a was also reported to repress erythroid cell cycle progression
and cell growth by targeting cyclin dependent kinase 2 (CDK2) and
Ago2 [29], resulting in erythroid differentiation inhibition. Coinci-
dence with previous studies, our study suggests that miR-376a
suppresses cell proliferation in HCC.
High AFP levels have been clinically shown to be an unfavorable
prognostic factor inHCCpatients [30] and to be correlatedwith poor
tumor differentiation [31]. In this study, we demonstrated that
patients with higher relative level of miR-376a in tumor/adjacent
non-tumor tissues have a higher frequency of high AFP levels. We
speculated that miR-376a may inhibit differentiation in HCC (need
to be determined), and elevated miR-376a was associated with
poor differentiation grade of HCC patients with high AFP level.
Furthermore, these results implicate the potential application of
Y. Zheng et al. / FEBS Letters 586 (2012) 2396–2403 2403miR-376a in prognosis prediction. Pitifully, the specimens had no
comprehensive prognostic information, so there is no direct
correlation analysis between miR-376a level and prognosis of HCC
patients. However, the molecular framework explaining the rela-
tionship of miR-376a and AFP are needed to investigate in future.
It is known thatmiRNA targetsmultiplemRNAs, and research on
miRNA will increasingly focus on miRNA-regulated networks [32].
Interestingly, using pathway analysis of their candidate target
genes, we discovered the hub gene of the network and validated it
as the functional target gene of miR-376a. Thus, the strategy of
pathway analysis of the candidate target gene is beneﬁcial to dis-
cover the biologically signiﬁcant target genes [33] and elucidate
the nature of the regulatory network composed ofmiRNAs and their
targets. In this study, we showed that miR-376a not only inhibited
PIK3R1 directly but up-regulated p85a (PIK3R1) partially in HCC.
More importantly, we demonstrated that knockdown of PIK3R1
via a siRNA system could repress Huh7 proliferation, which is con-
sistent with the previous report that the deletion or reduction of
p85a impaired B cell development and proliferation, delayed
embryonic body development and inhibited cell adhesion [34,35].
Previous report [36] that miR-29 activate p53 by targeting p85a
prompts us to investigate the effect of miR-376a on the level of
p53. We discovered that miR-376a and PIK3R1 had an opposite
effect on the level of p53, with miR-376a increasing but PIK3R1
decreasing (Fig. S1). Therefore, we suppose that miR-376a may
up-regulate p53 expression by targeting p85a.
In conclusion, decreased expression of miR-376a is a frequent
event in HCC, and the elevated miR-376a repressed cell prolifera-
tion and induced apoptosis in Huh7 cells by targeting p85a. Fur-
ther study is needed to observe the role of miR-376a in liver
regeneration, because the understanding about the dissection of
the molecular mechanisms regulating liver homeostasis would
widen horizons in developing new targeted therapies for liver
regeneration, cirrhosis, and primary liver cancer.
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